|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G01N 33/574 | |
| G01N 33/68 |
| (11) | Patento numeris | 2247954 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09774994.9 |
| Europos patento paraiškos padavimo data | 2009-11-20 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-11-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2011-07-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2009/006269 |
| Data | 2009-11-20 |
| (87) | Numeris | WO 2010/085235 |
| Data | 2010-07-29 |
| (30) | Numeris | Data | Šalis |
| 321393 | 2009-01-20 | US |
| (72) |
RÖDER, Heinrich, US
TSYPIN, Maxim, US
GRIGORIEVA, Julia, US
|
| (73) |
Biodesix Inc.,
P.O. Box 774872 1370 Bob Adams Drive, Steamboat Springs, CO 80477,
US
|
| (54) | SELECTION OF HEAD AND NECK CANCER PATIENTS FOR TREATMENT WITH DRUGS TARGETING EGFR PATHWAY |
| SELECTION OF HEAD AND NECK CANCER PATIENTS FOR TREATMENT WITH DRUGS TARGETING EGFR PATHWAY |